Microangiopathic hemolytic anemia: Difference between revisions
From IDWiki
(Imported from text file) Â |
m (→â€)  |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
== |
==Differential Diagnosis== |
||
* |
*Primary/[[Thrombotic microangiopathy|thrombotic microangiopathies]] (TMA) |
||
** |
**[[Thrombotic thrombocytopenic purpura]] (TTP) |
||
*** |
***Congenital ([[Upshaw-Shulman syndrome|Upshaw-Shulman]]) |
||
*** |
***Acquired |
||
** |
**[[Hemolytic-uremic syndrome]] (HUS) |
||
*** |
***Typical (Shiga-producing [[Escherichia coli]]) |
||
*** |
***[[Atypical hemolytic uremic syndrome]] (aHUS) (congenital complement-overactivation) |
||
* |
*Secondary |
||
** |
**[[Antiphospholid antibody syndrome]] |
||
** |
**[[Malignant hypertension]] |
||
** |
**[[Lymphoma|Lymphomas]] and solid tumours |
||
** |
**[[Scleroderma]] crisis |
||
** |
**Drug-associated: [[Calcineurin inhibitor|calcineurin inhibitors]], [[quinine]], [[ticlopidine]] |
||
** |
**[[Vasculitis]] |
||
** |
**Infections: [[HIV]], [[influenza]], [[EBV]], [[parvovirus]] |
||
** |
**[[Disseminated intravascular coagulation]] (DIC) |
||
** |
**[[HELLP syndrome]] |
||
[[Category:Hematology]] |
[[Category:Hematology]] |
||
Latest revision as of 16:07, 10 May 2023
Differential Diagnosis
- Primary/thrombotic microangiopathies (TMA)
- Thrombotic thrombocytopenic purpura (TTP)
- Congenital (Upshaw-Shulman)
- Acquired
- Hemolytic-uremic syndrome (HUS)
- Typical (Shiga-producing Escherichia coli)
- Atypical hemolytic uremic syndrome (aHUS) (congenital complement-overactivation)
- Thrombotic thrombocytopenic purpura (TTP)
- Secondary
- Antiphospholid antibody syndrome
- Malignant hypertension
- Lymphomas and solid tumours
- Scleroderma crisis
- Drug-associated: calcineurin inhibitors, quinine, ticlopidine
- Vasculitis
- Infections: HIV, influenza, EBV, parvovirus
- Disseminated intravascular coagulation (DIC)
- HELLP syndrome
